Barely Significant
← all excerpts

Effectiveness of Anti-Cluster of Differentiation 20 as a Disease-Modifying Therapy in Multiple Sclerosis Across Its Different Phenotypes at the University Hospital of Caen.

Cureus · 2022 · PMC8844373 · PMID 35186606

Europe PMCDOI
1
hedged sentence
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantP<0.0001actually significant
reported a highly significant difference in ocrelizumab groups (P<0.0001) for a total number of gadolinium-enhancing T1 lesions at weeks 12, 16, 20, and 24 versus placebo [ 19 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.